THERE is an urgent need for reforms to be introduced, particularly on the public sector’s procurement practices of medicines after Pharmaniaga Bhd was issued the Practice Note 17 (PN17), Galen Centre for Health and Social Policy said.
Its chief executive, Azrul Mohd Khalib, said Pharmaniaga’s classification as a financially distressed company is a wake-up call for the pharmaceutical sector.